|
⚲
|
| Braidwell LP
✚
| |
|---|---|
| CRD # | 316988 |
| SEC # | 801-122966 |
| CIK # | 0001920938 |
| AUM | $4.9 BB (2024-03-28) |
| Employees | 38 (53% Investors, 0% Brokers) |
| Phone | 866-453-3929 |
| Address | One Harbor Point, 2200 Atlantic Street Stamford, CT 06902 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($BB) |
|---|
| CIK | Period |
|---|---|
| 0001920938 | |
| / | |
| Sector | Form 13F Holdings | Cap ($BB) | Value ($BB) |
|---|---|---|---|
| Neurocrine Biosciences Inc | 9.3 | 0.1 | |
| CG Oncology Inc | 0.1 | ||
| Xenon Pharmaceuticals Inc | 1.6 | 0.1 | |
| Apogee Therapeutics Inc | 0.1 | ||
| Guardant Health Inc | 4.3 | 0.1 | |
| Legend Biotech Corp | 8.1 | 0.1 | |
| Argenx SE | 19.8 | 0.1 | |
| Align Technology Inc | 19.1 | 0.1 | |
| Maravai Lifesciences Holdings Inc | 3.7 | 0.1 | |
| Vaxcyte Inc | 1.2 | 0.1 | |
| Aeglea Biotherapeutics Inc | 0.1 | ||
| Glaukos Corp | 2.2 | 0.1 | |
| Viking Therapeutics Inc | 0.2 | 0.1 | |
| iRhythm Technologies Inc | 3.4 | 0.1 | |
| Inspire Medical Systems Inc | 5.2 | 0.1 | |
| Exact Sciences Corp | 7.2 | 0.0 | |
| Keros Therapeutics Inc | 0.6 | 0.0 | |
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
|---|---|---|---|---|
| HF | Braidwell Companion CMV LP | [2021-12-01] | 66.5 | 26.8 |
| HF | Braidwell Companion CMV Master Fund LP | 2021-12-01 | 8.8 | |
| HF | Braidwell Companion CMV Transaction Master Fund LP | 2021-12-01 | 13.5 | |
| HF | Braidwell Companion CMV US LP - 2023-1 Series | [2021-12-01] | 63.4 | 44.9 |
| HF | Braidwell Partners LP | [2021-12-01] | 2,763.6 | 2,474.1 |
| HF | Braidwell Partners Master Fund LP | 2021-12-01 | 3,274.5 | |
| HF | Braidwell Partners Transaction Master Fund LP | 2021-12-01 | 424.5 | |
| HF | Braidwell Partners US LP | [2021-12-01] | 1,270.6 | 1,224.9 |
| AUM Breakdown | Accounts | AUM ($BB) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 8 | 4.9 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 8 | 4.9 |
| By Discretionary | ||
| Discretionary | 8 | 4.9 |
| Non-Discretionary | 0 | 0.0 |
| Total | 8 | 4.9 |
| By Non-United States Persons | ||
| Non-United States Persons | 3.3 | |
| United States Persons | 1.6 | |
| Total | 8 | 4.9 |
| Form D Directors | # Filings | # Firms | 2011 - 2024 |
|---|---|---|---|
| Braidwell LP | 4 | ||
| Braidwell GP LLC | 4 | ||
| Brian Kreiter | 4 | ||
| Manish Mital | 4 | ||
| Alexander Karnal | 3 | ||
| Alexander Karal | 1 |
| EDGAR Form | CIK | 2011 - 2024 |
|---|---|---|
| 13F-HR | [0001920938] | |
| SC 13G | [0001920938] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Braidwell LP | DBV Technologies Sa | [2023-02-14] |
| Braidwell LP | Crinetics Pharmaceuticals Inc | [2023-02-14] |
| Braidwell LP | Deciphera Pharmaceuticals Inc | [2023-02-14] |
| Comparable Firms | State | AUM ($BB) |
|---|---|---|
|
TPG PEP Advisors LLC
✚
|
TX | 5.0 |
|
EcoR1 Capital LLC
✚
|
CA | 5.0 |
|
Empyrean Capital Partners LP
✚
|
CA | 5.0 |
|
Caledonia US LP
✚
|
NY | 5.0 |
|
STWD Investment Management LLC
✚
|
FL | 5.0 |
|
Crosslink Capital Inc
✚
|
CA | 4.9 |
|
Boulder Hill Capital Management LP
✚
|
NY | 4.9 |
|
Whitehaven Asset Management LP
✚
|
CT | 4.8 |
|
Greenvale Capital LLP
✚
|
4.8 | |
|
Aperture Investors LLC
✚
|
NY | 4.8 |